Union Korea Pharm Co., Ltd. (KOSDAQ: 080720)

Union Korea Pharm Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 10, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	19,700	35,741	51,626	78,193	145,429	82,062
Market Cap Growth	0.49%	-30.77%	-33.98%	-46.23%	77.22%	7.80%
Enterprise Value	51,099	69,920	79,902	92,488	152,610	101,825
Last Close Price	2725.00	4950.00	7150.00	10150.00	18400.00	12841.10
PE Ratio	-	-1.97	-56.61	-7.10	-12.86	184.68
PS Ratio	0.31	0.57	0.84	1.62	2.89	1.60
PB Ratio	0.84	1.18	1.06	1.46	2.13	1.41
P/FCF Ratio	3.78	-39.66	-6.12	-14.88	-14.49	-4.26
P/OCF Ratio	5.96	26.24	-10.20	40.84	-66.23	-25.21
EV/Sales Ratio	0.80	1.11	1.30	1.91	3.03	1.99
EV/EBITDA Ratio	-5.39	-6.48	15.17	-14.48	-21.54	31.18
EV/EBIT Ratio	-4.25	-4.76	62.84	-8.71	-14.09	128.68
EV/FCF Ratio	9.81	-77.59	-9.48	-17.60	-15.20	-5.28
Debt / Equity Ratio	1.66	1.30	0.76	0.67	0.22	0.47
Debt / EBITDA Ratio	-	-	7.05	-	-	8.43
Debt / FCF Ratio	7.49	-43.67	-4.40	-6.83	-1.52	-1.43
Asset Turnover	0.64	0.61	0.53	0.45	0.52	0.56
Inventory Turnover	3.52	4.11	3.18	2.72	2.52	2.61
Quick Ratio	0.57	0.70	0.70	1.11	1.28	1.45
Current Ratio	0.77	0.84	0.93	1.36	1.91	1.85
Return on Equity (ROE)	-65.16%	-46.00%	-1.82%	-18.22%	-14.75%	0.71%
Return on Assets (ROA)	-10.49%	-8.87%	0.69%	-6.14%	-6.99%	0.54%
Return on Capital (ROIC)	-14.49%	-11.81%	0.91%	-7.66%	-8.00%	0.62%
Earnings Yield	-115.77%	-50.80%	-1.81%	-14.21%	-6.41%	0.50%
FCF Yield	26.43%	-2.52%	-16.33%	-6.72%	-6.90%	-23.48%
Buyback Yield / Dilution	0.29%	2.14%	5.05%	-16.95%	-12.55%	-17.33%
Total Shareholder Return	0.29%	2.14%	5.05%	-16.95%	-12.55%	-17.33%

Source: S&P Capital IQ. Standard template. Financial Sources.